Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus: A Prospective, Multicenter, Randomized, Blank-controlled，Blinded End-point Study.

NCT03948347 is registered in ClinicalTrials.gov with First Affiliated Hospital of Jinan University as lead sponsor.

NCT NCT03948347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03948347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus: A Prospective, Multicenter, Randomized, Blank-controlled，Blinded End-point Study.
Lead sponsor
First Affiliated Hospital of Jinan University
Phase
Not applicable
Overall status
Unknown status
Start date
June 25, 2019
Completion date
June 30, 2024
Enrollment
1,708 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, transient ischemic attack, type 2 diabetes mellitus